WASHINGTON (Reuters) - The White House announced on Wednesday measures aimed at advancing President Barack Obama's precision medicine initiative, including plans to speed the development of tests used to identify genetic mutations and guide medical treatment.div class="feedflare"
a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=r3XUsaQL8SM:cMo--T_riaE:yIl2AUoC8zA"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?d=yIl2AUoC8zA" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=r3XUsaQL8SM:cMo--T_riaE:F7zBnMyn0Lo"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=r3XUsaQL8SM:cMo--T_riaE:F7zBnMyn0Lo" border="0"/img/a a href="http://feeds.feedburner.com/~ff/reuters/scienceNews?a=r3XUsaQL8SM:cMo--T_riaE:V_sGLiPBpWU"img src="http://feeds.feedburner.com/~ff/reuters/scienceNews?i=r3XUsaQL8SM:cMo--T_riaE:V_sGLiPBpWU" border="0"/img/a
/divimg src="http://feeds.feedburner.com/~r/reuters/scienceNews/~4/r3XUsaQL8SM" height="1" width="1" alt=""/